Mometasone Furoate Topical Solution — Class II drug recall D-0327-2021
Terminated recall by Cosette Pharmaceuticals, Inc., reported 2021-04-14, distributed nationwide. CGMP Deviaitons
| Recall number | D-0327-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cosette Pharmaceuticals, Inc., South Plainfield, NJ, United States |
| Recall initiated | 2021-03-25 |
| Classified | 2021-04-07 |
| Reported by FDA | 2021-04-14 |
| Terminated | 2023-07-17 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 00713-0701-53, 00713-0701-85 |
| Expiration dates | 2022-10, 2022-12 |
Product
Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080
Reason for recall
CGMP Deviaitons
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0327-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.